Found: 8
Select item for more details and to access through your institution.
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 7, p. 493, doi. 10.1038/nrd839
- By:
- Publication type:
- Article
The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib).
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 6, p. 2267, doi. 10.3892/ijo.2014.2683
- By:
- Publication type:
- Article
A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo.
- Published in:
- International Journal of Cancer, 1998, v. 76, n. 1, p. 154, doi. 10.1002/(SICI)1097-0215(19980330)76:1<154::AID-IJC24>3.0.CO;2-B
- By:
- Publication type:
- Article
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.
- Published in:
- Nature Genetics, 2004, v. 36, n. 5, p. 453, doi. 10.1038/ng1343
- By:
- Publication type:
- Article
In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
- Published in:
- Cardiovascular Research, 2008, v. 79, n. 1, p. 118, doi. 10.1093/cvr/cvn063
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors: From rational design to clinical trials.
- Published in:
- Medicinal Research Reviews, 2001, v. 21, n. 6, p. 499, doi. 10.1002/med.1022
- By:
- Publication type:
- Article
Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors.
- Published in:
- British Journal of Haematology, 1998, v. 100, n. 2, p. 295, doi. 10.1046/j.1365-2141.1998.00564.x
- By:
- Publication type:
- Article